Sfoglia per AUTORE
BRIA E
Collezione AOU San Luigi di Orbassano

  

Items : 43

MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database. in ESMO open / ESMO Open. 2024 Sep;9(9):103680. doi: 10.1016/j.esmoop.2024.103680. Epub 2024 Aug 29.
2024
ASL Asti
AOU San Luigi di Orbassano

Baldini E; Di Micco C; Banini M; Calvetti L; Leone F; Carta A; Pignataro D; Pozzessere D; Muscolino P; Bria E; Citarella F; Pilotto S; Cortinovis D; Gariazzo E; Pelizzari G; Roca E; Galetta D; Sini C; Delmonte A; Bulotta A; Occhipinti M; Minuti G; Cappuzzo F; Reale ML; Passiglia F; Favaretto A; Malapelle U; Novello S; Pasello G; et alii...

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.
2024
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Salerno F; Silva RR; Baldini E; Cortellini A; Brighenti M; Santoni M; Malorgio F; Caminiti C; Tiseo M; Camerini A; Carta A; Follador A; Zoratto F; Cortinovis DL; Berardi R; Toschi L; Citarella F; Bulotta A; Rastelli F; Adamo V; Manzo A; Cecere FL; Guida A; Belluomini L; Roca E; Pasello G; Montrone M; Cerea G; Delcuratolo MD; et alii...

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study. in Frontiers in oncology / Front Oncol. 2024 Jul 9;14:1436588. doi: 10.3389/fonc.2024.1436588. eCollection 2024.
2024
AOU San Luigi di Orbassano

Sposito M; Belluomini L; Nocini R; Insolda J; Scaglione IM; Menis J; Simbolo M; Lugini A; Buzzacchino F; Verderame F; Spinnato F; Aprile G; Calvetti L; Occhipinti M; Marinelli D; Veccia A; Lombardo F; Soto Parra HJ; Ferraù F; Savastano C; Porta C; Pradelli L; Sicari E; Castellani S; Malapelle U; Novello S; Bria E; Pilotto S; Milella M; et alii...

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2023 May;18(5):576-586. doi: 10.1016/j.jtho.2022.12.018. Epub 2023 Jan 13.
2023
AOU San Luigi di Orbassano

Aldea M; Marinello A; Duruisseaux M; Zrafi W; Conci N; Massa G; Metro G; Monnet I; Gomez Iranzo P; Tabbo F; Bria E; Guisier F; Vasseur D; Lindsay CR; Ponce-Aix S; Cousin S; Citarella F; Fallet V; Minatta JN; Eisert A; de Saint Basile H; Audigier-Valette C; Mezquita L; Calles A; Mountzios G; Tagliamento M; Remon Masip J; Raimbourg J; Terrisse S; et alii...

2023
AOU San Luigi di Orbassano

Celio L; Cortinovis D; Cogoni AA; Cavanna L; Martelli O; Carnio S; Collovà E; Bertolini F; Petrelli F; Cassano A; Chiari R; Zanelli F; Pisconti S; Vittimberga I; Letizia A; Misino A; Gernone A; Bonizzoni E; Pilotto S; De Placido S; Bria E;

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Righi L; Novello S; Graziano P; Scagliotti GV; Bria E; Volante M; Rossi A; Rossi G; Osman G; Di Maio M; Bareggi C; Del Conte A; Cappuzzo F; Cortinovis D; Pilotto S; Gregorc V; Sergi C; Ghilardi L; Scotti V; Martelli O; Tiseo M; Galetta D; Maiello E; Rigutto A; Castellana S; Trombetta D; Gobbini E; Tabbò F; Muscarella LA; et alii...

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Russano M; Porzio G; Tiseo M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Metro G; Spinelli GP; Passiglia F; Migliorino MR; Ricciardi S; Pecci F; Zoratto F; De Tursi M; Di Marino P; Mansueto G; Tuzi A; Gori S; Della Gravara L; Rastelli F; Chiari R; Macerelli M; Marchetti P; Gelibter A; Antonuzzo L; Berardi R; et alii...

Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities. in ESMO open / ESMO Open. 2022 Feb;7(1):100308. doi: 10.1016/j.esmoop.2021.100308. Epub 2021 Dec 21.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Milella M; Pastorino U; Rolli L; Infante M; Capella C; Bria E; Pilotto S; Fontanini G; Mastracci L; Volante M; Mangogna A; Grillo F; Mafficini A; Ciaparrone C; Sabella G; Taormina S; Garzone G; Ali G; Simbolo M; Centonze G; Scarpa A; Milione M;

2022
AOU San Luigi di Orbassano

Cassano A; Chiari R; Zanelli F; Pisconti S; Vittimberga I; Letizia A; Misino A; Gernone A; Bonizzoni E; Pilotto S; De Placido S; Bria E; Celio L; Cortinovis D; Cogoni AA; Cavanna L; Martelli O; Carnio S; Collovà E; Bertolini F; Petrelli F;

2021
AOU San Luigi di Orbassano

Celio L; Cortinovis D; Cogoni AA; Cavanna L; Martelli O; Carnio S; Collovà E; Bertolini F; Petrelli F; Cassano A; Chiari R; Zanelli F; Pisconti S; Vittimberga I; Letizia A; Misino A; Gernone A; Bonizzoni E; Pilotto S; De Placido S; Bria E;

2021
AOU San Luigi di Orbassano

Passaro A; Novello S; Giannarelli D; Bria E; Galetta D; Gelibter A; Reale ML; Carnio S; Vita E; Stefani A; Pizzutilo P; Stati V; Attili I; de Marinis F;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

2021
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; et alii...

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ? 50%: a multicenter study with external validation. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001403. doi: 10.1136/jitc-2020-001403.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Giusti R; Porzio G; Ficorella C; Petrelli F; Addeo A; De Toma A; Friedlaender A; Tabbò F; Ricciardi S; Della Gravara L; Guaitoli G; Landi L; Scodes S; Buti S; Nigro O; Ferrara MG; Targato G; Cantini L; Russano M; Citarella F; Pizzutilo P; Filetti M; Grossi F; Zoratto F; Mansueto G; De Tursi M; Di Marino P; Rocco D; Inno A; et alii...

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ? 50% and Their Relationship With Clinical Outcomes. in Clinical lung cancer / Clin Lung Cancer. 2020 Nov;21(6):498-508.e2. doi: 10.1016/j.cllc.2020.06.010. Epub 2020 Jun 21.
2020
AOU San Luigi di Orbassano

Belderbos RA; De Filippis M; Dal Bello MG; Della Gravara L; Bertolini F; Baldessari C; Guaitoli G; Landi L; Antonuzzo L; Scodes S; Pettoruti L; Leonetti A; D'Argento E; Ferrara MG; Nigro O; Sforza V; Follador A; Torniai M; Cantini L; Russano M; Citarella F; Occhipinti MA; Sala L; Pizzutilo P; Catino A; Filetti M; Ghidini M; Tudini M; Santoni M; et alii...

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ??50. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2020 Nov;69(11):2209-2221. doi: 10.1007/s00262-020-02613-9. Epub 2020 May
2020
AOU San Luigi di Orbassano

Dal Bello MG; Della Gravara L; Baldessari C; Guaitoli G; Landi L; Scodes S; Antonuzzo L; Bordi P; Buti S; D'Argento E; Ferrara MG; Sforza V; Nigro O; Targato G; Cantini L; Torniai M; Marco R; Citarella F; Sala L; Pizzutilo P; Catino A; Filetti M; Rijavec E; Tudini M; Santoni M; Zoratto F; Mansueto G; De Tursi M; Gori S; et alii...

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino

Banna GL; Camisa R; Di Maio M; Rossi G; Rossi A; Cortinovis DL; Bria E; Novello S; Baldessari C; Bartoli G; Pizzutilo EG; Landi L; Toschi L; Dall'Olio FG; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Camerini A; Bearz A; Sala E; Cerea G; Migliorino MR; Bennati C; Ardizzoni A; Vita E; Rossi S; et alii...

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano

Novello S; Tiseo M; Di Maio M; Galetta D; Bria E; Rossi G; Cortinovis D; Rizzo P; Tabbò F; Delmonte A; Bareggi C; Sergi C; Del Conte A; Graziano P; Gregorc V; Casartelli C; Rossi A; Borra G; Maiello E; Martelli O; Scotti V; Riccardi F; Cecere F; Cappuzzo F; Pilotto S; Osman G; Ghilardi L; Pizzutillo P; Bordi P; et alii...

Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate Cancer. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2020 Feb;18(1):69-76.e4. doi: 10.1016/j.clgc.2019.09.010. Epub 2019 Sep 27.
2020
AOU San Luigi di Orbassano

Pappagallo G; Galli L; Gelderblom H; Tucci M; De Giorgi U; Zagonel V; Sella A; Bournakis E; Yu EY; Schmid S; Thomsen FB; Bergman A; Bianchini D; Wissing M; Caffo O; Bria E; Sperduti I; Oudard S;

Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Sep;14(9):1651-1661. doi: 10.1016/j.jtho.2019.05.003. Epub 2019 May 11.
2019
AOU San Luigi di Orbassano

Scarpa A; Volante M; Fontanini G; Lawlor RT; Tortora G; Pelliccioni S; Pelosi G; Pilotto S; Grillo F; Mastracci L; Rusev B; Corbo V; Sperandio N; Vicentini C; Ali G; Mafficini A; Barbi S; Fassan M; Simbolo M; Bria E;

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.
2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Novello S; Migliaretti G; Pacchiana MV; Stura I; Critelli R; Metro G; Morelli AM; Manzo A; Ricciardi S; Bria E; Colantonio I; Ciuffreda L; Pisconti S; Ceresoli GL; Del Conte A; Gregorc V; Scotti V; Galetta D; Romano G; Grossi F; Delmonte A; Costanzo FD; Tiseo M; Chiari R; Morabito A; Capelletto E; Migliorino MR;

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach. in PloS one / PLoS One. 2019 Nov 13;14(11):e0224027. doi: 10.1371/journal.pone.0224027. eCollection 2019.
2019
AOU San Luigi di Orbassano

Taraborrelli M; Paci M; Tiseo M; Botti A; Bria E; Baldini E; Vagge S; Banna G; Perna M; Capelletto E; Franceschini D; Borghetti P; Greco C; Greco S; Grossi F; Bonti V; Ferrari K; Maragna V; Ciammella P; Giaj-Levra N; Bruni A; Poletti V; Granone P; Ricardi U; Novello S; Scotti V;

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.
2018
AOU San Luigi di Orbassano

Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; Aglietta M; Cagnazzo C; Sperduti I; Bria E; Novello S;

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2018 Jun;26(6):1841-1849. doi: 10.1007/s00520-017-4004-1. Epub 2017 Dec 21.
2018
AOU San Luigi di Orbassano

Carnio S; Galetta D; Scotti V; Cortinovis DL; Antonuzzo A; Pisconti S; Rossi A; Martelli O; Cecere FL; Lunghi A; Del Conte A; Montagna ES; Topulli J; Pelizzoni D; Rapetti SG; Gianetta M; Pacchiana MV; Pegoraro V; Cataldo N; Bria E; Novello S;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.
2018
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2018 Apr;472(4):567-577. doi: 10.1007/s00428-018-2307-3. Epub 2018 Feb 1.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bria E; Albini A; Mastracci L; Fontanini G; Volante M; Harari S; Papotti M; Pilotto S; Sonzogni A; Mafficini A; Simbolo M; Dama E; Bianchi F; Pelosi G; Scarpa A; Calabrese F;

Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Apr;13(4):568-575. doi: 10.1016/j.jtho.2017.12.003. Epub 2017 Dec 18.
2018
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Leuzzi G; Chiappetta M; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Novello S; Milella M; Santo A; Scarpa A; Infante M; Tortora G; Facciolo F; Bria E;

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AO Ordine Mauriziano

Novello S; Bordi P; Catino A; Pisconti S; Cortinovis D; Franchina T; Migliorino MR; Delmonte A; Buffoni L; Ceribelli A; Scotti V; Riccardi F; Gregorc V; Di Maio M; Rossi G; Bria E; Rossi A; Graziano P; Tiseo M; Galetta D; Gobbini E; Maiello E; Arizio F;

2017
AOU San Luigi di Orbassano

Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A;

2017
AOU San Luigi di Orbassano

Pilotto S; Simbolo M; Gkountakos A; Mafficini A; Vicentini C; Sperduti I; Ludovini V; Chiari R; Novello S; Milella M; Carbognin L; Caregnato E; Santo A; Infante M; Brunelli M; Corbo V; Scarpa A; Tortora G; Bria E;

2017
AOU San Luigi di Orbassano

Pilotto S; Simbolo M; Gkountakos A; Mafficini A; Vicentini C; Sperduti I; Ludovini V; Chiari R; Novello S; Milella M; Carbognin L; Caregnato E; Santo A; Infante M; Brunelli M; Corbo V; Scarpa A; Tortora G; Bria E;

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Galli L; Fratino L; Rossetti S; Iacovelli R; Re GL; Mosillo C; Gasparro D; Guglielmini PF; Damiani A; Procopio G; De Lisi D; Ruatta F; Scagliarini S; Donini M; Sperduti I; Basso U;

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Biasco E; Fratino L; Facchini G; Iacovelli R; Re GL; Scagnoli S; Morelli F; D'Angelo A; Verderame F; Campadelli E; Ricotta R; Napolitano M; Sartori D; Borsellino N; Sperduti I; Maruzzo M;

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Galli L; Fratino L; Facchini G; Iacovelli R; Mucciarini C; Zucali PA; Vicario G; Carrozza F; Sirotova Z; Messina C; Bordonaro R; La Torre L; Sacco C; Veccia A; Sperduti I; Zagonel V;

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Galli L; Fratino L; Facchini G; Iacovelli R; Re GL; Mosillo C; Gasparro D; Guglielmini P; Damiani A; Procopio G; De Lisi D; Ortega C; Scagliarini S; Donini M; Sperduti I; Basso U;

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Biasco E; Fratino L; Rossetti S; Iacovelli R; Morelli F; D'Angelo A; Campadelli E; Verderame F; Borsellino N; Sartori D; Guida A; Ricotta R; Barni S; Maines F; Sperduti I; Zagonel V;

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Galli L; Fratino L; Rossetti S; Iacovelli R; Re GL; Mosillo C; Gasparro D; Guglielmini P; Damiani A; Procopio G; De Lisi D; Ortega C; Scagliarini S; Donini M; Sperduti I; Basso U;

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.
2016
AOU San Luigi di Orbassano
AOU Alessandria

Rossi A; Spitaleri G; Bria E; Cecere F; Rijavec E; Rizzo E; Barbieri F; Menis J; Filipazzi V; Mucciarini C; Genestreti G; Bearz A; Barzelloni ML; Ardizzoia A; Banna GL; Casartelli C; Zilembo N; Cortinovis D; Piovano PL; Caffo O; Novello S; Martelli O; Di Maio M; Morabito A; Vavalà T; Follador A; Tiseo M; Galetta D;

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10.
2016
AOU San Luigi di Orbassano

Facchinetti F; Tiseo M; Di Maio M; Graziano P; Bria E; Rossi G; Novello S;

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.
2015
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E;

2015
AOU San Luigi di Orbassano

Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G;

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.
2015
AOU San Luigi di Orbassano

Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A;

Maintenance therapy in NSCLC: why? To whom? Which agent? in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2011 May 6;30(1):50. doi: 10.1186/1756-9966-30-50.
2011
AOU San Luigi di Orbassano

Novello S; Milella M; Tiseo M; Banna G; Cortinovis D; Di Maio M; Garassino M; Maione P; Martelli O; Vavalà T; Bria E;